GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.01 and traded as low as $0.00. GB Sciences shares last traded at $0.00, with a volume of 86,475 shares.
GB Sciences Trading Down 8.0 %
About GB Sciences
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
Further Reading
- Five stocks we like better than GB Sciences
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Most active stocks: Dollar volume vs share volume
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- What is the NASDAQ Stock Exchange?
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
